Arcus Biosciences Inc share price logo

Arcus Biosciences Inc Share Price

NYSE: RCUS

Mid Cap

$25.55

+0.05

(+0.20%)

Live

as on

Arcus Biosciences Inc Stock Performance

as on April 28, 2026 at 3:09 am IST

  • Day's Low

    Day's High

    $25.21
    $26.20
    downward going graph

    1.33%

    Downside

    2.54%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.06
    $28.72
    downward going graph

    72.37%

    Downside

    12.41%

    Upside

    downward going graph

Arcus Biosciences Inc share price movements today

Previous Close
$25.50
Open
$25.29
Volume
195.7K
Day's Low - High
$25.21 - $26.20
52 Week Low - High
$7.06 - $28.72

Arcus Biosciences Inc Historical Returns

1 Month Return
+ 25.74 %
3 Month Return
+ 10.92 %
1 Year Return
+ 207.23 %
3 Year Return
+ 45.63 %
5 Year Return
-26.6 %

Arcus Biosciences Inc Stock Fundamentals & Key Indicators

Check Arcus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2B

EPS (TTM)

-3.645

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-376.0M

Revenue (TTM)

247.0M

Profit Margin

-142.92%

Return On Equity TTM

-63.26%

Arcus Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.2B-26.6%NA-142.92%
BUY$40.8B116.23%131.78.45%
BUY$109.5B99.64%28.132.94%
NA$33.4BNA121.785.37%
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for Arcus Biosciences Inc Stock including INR - Dollar returns

The Arcus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arcus Biosciences Inc investment value today

Current value as on today

₹3,40,462

Returns

₹2,40,462

(+240.46%)

Returns from Arcus Biosciences Inc Stock

₹2,07,831 (+207.83%)

Dollar Impact

₹32,631 (+32.63%)

Analyst Recommendation on Arcus Biosciences Inc Stock

Based on 18 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Arcus Biosciences Inc. Average target price of $34

Arcus Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Arcus Biosciences Inc.

What analysts predicted

24.85%UPSIDE

Target Price

$34

Current Price

$25.55

Analyzed by

18 Analysts

Target

$34.00

Arcus Biosciences Inc target price $34, a slight upside of 24.85% compared to current price of $25.55. According to 18 analysts rating.

Arcus Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Arcus Biosciences Inc Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

Arcus Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
32
31
145
39
48
26
28
160
26
33
Gross Profit
32
31
145
39
48
26
28
160
24
30
Operating Income
-80
-91
-16
-106
-105
-103
-122
-8
-142
-114
EBITDA
-67
-77
20
-91
-89
-89
-108
4
-130
-81
Interest Expense
1
2
1
-
1
2
1
2
3
14
Depreciation
1
3
3
2
2
3
3
2
2
3
Income Before Tax
-69
-80
-4
-93
-92
-94
-112
-8
-135
-98
Income Tax Expense
2
1
1
-
-
1
-
-
-
-
Net Income
-71
-81
-4
-93
-92
-94
-112
-8
-135
-98
Net Profit Margin
-221.88%
-261.29%
-2.76%
-238.46%
-191.67%
-361.54%
-400.00%
-5.00%
-519.23%
-296.97%

Arcus Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
1
8
15
78
383
112
117
258
247
Gross Profit
-1
1
8
15
78
383
112
117
258
237
Operating Income
-18
-53
-54
-88
-124
54
-280
-340
-330
-386
EBITDA
-16
-50
-51
-85
-120
59
-258
-291
-269
-335
Interest Expense
-
-
4
-
-
0
2
2
4
8
Depreciation
-
2
3
3
4
3
6
8
10
10
Income Before Tax
-17
-53
-49
-84
-123
55
-266
-301
-283
-353
Income Tax Expense
-
-
5
-8
-6
2
1
6
1
-
Net Income
-17
-53
-49
-75
-123
53
-267
-307
-283
-353
Net Profit Margin
0.00%
-3756.69%
-593.73%
-506.21%
-157.69%
13.84%
-238.39%
-262.39%
-109.69%
-142.91%

Arcus Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-81
-4
-93
-92
-94
-112
-
-135
-106
Operating Cash Flow
-88
-2
-94
26
-100
-132
-133
-97
-120
Investing Cash Flow
28
-169
63
-29
51
32
137
79
-182
Financing Cash Flow
3
229
2
48
-2
142
52
8
286
Change in Cash
-57
58
-29
45
-51
42
56
-10
-16

Arcus Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-49
-84
-122
52
-267
-307
-283
-353
Operating Cash Flow
-25
-42
-73
111
-256
438
-306
-170
-482
Investing Cash Flow
-49
-113
59
-434
-3
-413
194
-84
66
Financing Cash Flow
107
129
1
438
237
33
33
277
488
Change in Cash
33
-27
-13
115
-22
58
-79
23
72

Global Institutional Holdings in Arcus Biosciences Inc

Funds
Holdings
BlackRock Inc
9.42%
Samlyn Capital, LLC
1.28%
Northern Trust Corp
0.65%
Geode Capital Management, LLC
1.28%
Parkman Healthcare Partners LLC
0.77%

Insights on Arcus Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 26.0M → 33.0M (in $), with an average increase of 21.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RCUS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RCUS stock has moved up by 12.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RCUS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -135.0M → -98.0M (in $), with an average increase of 37.8% per quarter

About Arcus Biosciences Inc

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
OrganisationArcus Biosciences Inc
Headquarters3928 Point Eden Way, Hayward, CA, United States, 94545
IndustryBiotechnology
CEODr. Terry J. Rosen Ph.D.
E-voting on sharesClick here to vote

Key Management of Arcus Biosciences Inc

Name

Title

Dr. Terry J. Rosen Ph.D.

Co-Founder, Chairman & CEO

Ms. Jennifer A. Jarrett M.B.A.

Advisor

Dr. Richard A. Markus M.D., Ph.D.

Chief Medical Officer

Dr. Jonathan Yingling Ph.D.

Chief Scientific Officer

Holli Kolkey

Vice President of Corporate Communications

Dr. Juan Carlos Jaen Ph.D.

Co- Founder & President

Mr. Robert C. Goeltz II

Principal Financial Officer & CFO

Dr. K. Christopher Garcia Ph.D.

Co-Founder & Member of Scientific Advisory Board

Pia Eaves

Vice President of Investor Relations & Strategy

Ms. Carolyn C. Tang J.D.

General Counsel & Corporate Secretary

FAQs

What is Arcus Biosciences Inc share price today?

Arcus Biosciences Inc share price today is $25.55 as on . Arcus Biosciences Inc share today touched a day high of $26.2 and a low of $25.21.

What is the 52 week high and 52 week low for Arcus Biosciences Inc share?

Arcus Biosciences Inc share touched a 52 week high of $28.72 on and a 52 week low of $7.06 on . Arcus Biosciences Inc stock price today i.e. is trending at $25.55,which is 11.04% down from its 52 week high and 261.90% up from its 52 week low.

What is Arcus Biosciences Inc's market capitalisation today?

Arcus Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Arcus Biosciences Inc Stock (RCUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcus Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcus Biosciences Inc Shares that will get you 0.0587 shares as per Arcus Biosciences Inc share price of $25.55 per share as on April 27, 2026 at 9:39 pm IST.

What is the minimum amount required to buy Arcus Biosciences Inc Stock (RCUS) from India?

Indian investors can start investing in Arcus Biosciences Inc (RCUS) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in Arcus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcus Biosciences Inc share’s latest price of $25.55 as on April 27, 2026 at 9:39 pm IST, you will get 0.3914 shares of Arcus Biosciences Inc. Learn more about fractional shares .

What are the returns that Arcus Biosciences Inc has given to Indian investors in the last 5 years?

Arcus Biosciences Inc stock has given -26.6% share price returns and 26.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?